Uganda Heart Institute
Kampala, Central Region
- UEI
- QC3ZDGSKM9N4
- CAGE
- SEDP5
- Primary NAICS
- 622110 General Medical and Surgical Hospitals
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- SAM.gov registration date
- Physical address
- Mulago, Kampala, Uganda
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Childrens Hospital Medical Center | R33HL166441 | $680,919 | |
| Childrens Hospital Medical Center | R01HL164615 | $293,862 | |
| Childrens Hospital Medical Center | R33HL166441 | $875,027 | |
| Childrens Hospital Medical Center | R01HL164615 | $284,969 | |
| Childrens Hospital Medical Center | R33HL166441 | $210,214 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Mbale Clinical Research Institute LIMITED | Mbale, Eastern Region | — |
| Uganda Society For Health Scientists | Kampala, Central Region | 541990 All Other Professional, Scientific, and Technical Services |
| Hisp Uganda | Kampala, Central Region | 541512 Computer Systems Design Services |
| Makerere University College Of Health Sciences | Kampala, Central Region | — |
| Joint Clinical Research Centre | Kampala, Central Region | 622110 General Medical and Surgical Hospitals |
About the company
Uganda Heart Institute, a non-profit hospital located in Kampala, Uganda, operates as a sub-recipient on federal research grants focused on rheumatic heart disease prevention and treatment, with no prime contract or grant awards in its federal footprint. All five recent federal sub-awards flow through Children's Hospital Medical Center as the prime grantee, with funding from the National Institutes of Health's National Heart, Lung, and Blood Institute (NHLBI).
Uganda Heart Institute's federal work centers on two parallel research initiatives addressing rheumatic heart disease in Uganda. The GOALIE trial (Intramuscular vs Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease) spans three sub-awards dated February 2024, March 2025, and April 2026, evaluating non-inferiority of intramuscular versus enteral penicillin prophylaxis. Parallel sub-awards dated September 2024 and December 2025 fund Accelerating Delivery of Rheumatic Heart Disease Preventive Interventions in Uganda (ADUNU), which focuses on implementation and delivery acceleration of preventive interventions. Combined obligated dollars across all five sub-awards total $2.3 million, with the institute serving as a single federal customer (NHLBI) across the active portfolio.
Activity has remained steady at two awards per year in 2024 and 2025, with one award recorded in 2026 to date. Uganda Heart Institute operates entirely in a sub-recipient capacity under the Children's Hospital Medical Center prime relationship, with no independent federal contracting or grant-recipient authority. The institute's federal role is specialized and singular: clinical trial and implementation research site for NHLBI-funded rheumatic heart disease prevention work in Uganda, with no diversification across other agencies, programs, or therapeutic areas.
Quick answers
Is Uganda Heart Institute registered in SAM.gov?
Yes. Uganda Heart Institute's SAM.gov registration is active through February 20, 2027.
On GovTribe
See Uganda Heart Institute's full federal record
- Similar vendors